Silencing of the mammary-derived growth inhibitor (MDGI) gene in breast neoplasms is associated with epigenetic changes

Cancer Research

Volumn 56, Issue 21, 1996, Pages 4865-4870

  Huynh, Hung ^a,b   Alpert, Lesley ^a,b   Pollak, Michael ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ANTINEOPLASTIC AGENT; GROWTH INHIBITOR;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CANCER CELL CULTURE; DNA METHYLATION; GENE EXPRESSION; GENE MUTATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

AZACITIDINE; BREAST NEOPLASMS; CARRIER PROTEINS; DNA METHYLATION; FATTY ACID-BINDING PROTEINS; FEMALE; GROWTH INHIBITORS; HUMANS; POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0029960684     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Bohmer, F. D., Kraft, R., Otto, A., Wernstedt, C., Hellman, U., Kurtz, A., Muller, T., Rohde, K., Etzold, G., Lehmann, W., Langen, P., Heldin, C H., and Grosse, R. Identification of a polypeptide growth inhibitor from bovine mammary gland J Biol Chem., 262: 15137-15143, 1987.
2. Spener, F., Unterberg, C., Börchers, T., and Grosse, R Characteristics of fatty acid-binding proteins and their relation to mammary-derived growth inhibitor. Mol. Cell Biochem., 98: 57-68, 1990.
3. Veerkamp, J. H., Peeters, R A., and Maatman, R G. H J Structural and functional features of different types of cytoplasmic fatty acid-binding proteins. Biochim. Biophys. Acta, 1081: 1-24, 1991.
4. Bohmer, F D., Mieth, M., Reichmann, G., Taube, C., Grosse, R., and Hollenberg, M. A polypeptide growth inhibitor isolated from lactating bovine mammary gland (MDGI) is a lipid-carrying protein. J Cell. Biochem., 38: 199-204, 1988.
5. Grosse, R., Bohmer, F. D., Binas, B., Kurtz, A., Spitzer, E., Müller, T., and Zschiesche, W Mammary derived growth inhibitor. In: R. B. Dickson and M. E Lippman (eds), Genes, Oncogenes, and Hormones, pp 69-96 Boston, MA: Kluher, 1993.
6. Huynh, H. T., Larsson, C., Narod, S., and Pollak, M. Tumor suppressor activity of the gene encoding mammary-derived growth inhibitor Cancer Res., 55: 2225-2231, 1995.
7. Bieche, I., Champeme, M., and Lidereau, R. A tumor suppressor gene on chromosome 1p32-pter controls the amplification of myc family genes in breast cancer. Cancer Res., 54: 4274-4276, 1994.
8. Bieche, I., Champeme, M. H., Matifas, F., Cropp, C. S., Callahan, R., and Lidereau, R Two distinct regions involved in Ip deletion in human primary breast cancer. Cancer Res., 53: 1990-1994, 1993.
9. Nielsen, S U., and Spener, F. Fatty acid-binding protein from rat heart is phosphorylated on Tyr19 in response to insulin stimulation. J. Lipid Res., 34: 1355-1366, 1993.
10. Wobus, A. M., Zschiesche, W., and Grosse, R. Differentiation-promoting effects of mammary-derived growth inhibitor (MDGI) on pluripotent mouse embryonic stem cells. Virchows Arch. B Cell. Pathol., 59: 339-342, 1990.
11. Binas, B., Spitzer, E., Zschiesche, W., Erdmann, B., Kurtz, A., Müller, T., Niemann, C., Blenau, W., and Grosse, R Hormonal induction of functional differentiation and mammary derived growth inhibitor expression in cultured mouse mammary gland explants In Vitro Cell. Dev. Biol., 28A: 625-634, 1992.
12. Scholz, H., Kohlwein, S., Paltauf, F., Lezius, A., and Spener, F. Expression of a functionally active cardiac fatty acid-binding protein in the yeast, Saccharomyces cerevisiae. Mol. Cell. Biochem., 98: 69-74, 1990.
13. Böhmer, F., Lehman, W., Schmidt, H. E., Langen, P., and Gross, R. Purification of a growth inhibitor of Ehrlich ascites mammary carcinoma cells from bovine mammary gland. Exp. Cell. Res., 150: 466-476, 1984.
14. Phelan, M C., Larson, C., Baird, S., Futreal, A., Ruttledge, H M., Morgan, K., Tonin, P., Huynh, H. T., Komeluk, R. G., Pollak, M., and Narod, S A The human mammary-derived growth inhibitor (MDGI) gene genomic structure and mutation analysis in human breast tumours. Genomics, 34: 63-68, 1996.
15. Adams, R. L. P. DNA methylation, the effect of minor bases on DNA-protein interactions Biochem. J., 265: 309-320, 1990.
16. Counts, J L., and Goodman, J I. Alterations in DNA methylation may play a variety of roles in carcinogenesis. Cell, 83: 13-15, 1995.
17. Kautiamen, T. L., and Jones, P. A. DNA methyltransferase levels in tumorigenic and nontumorigenic cells in culture. J. Biol Chem., 261: 1594-1598, 1986.
18. el-Deiry, W S., Nelkin, B. D., Celano, P., Yen, R W., Falco, J. P., Hamilton, S. R., and Baylin, S. B. High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer Proc Natl. Acad. Sci. USA, 88: 3470-3474, 1991.
19. Issa, J. P., Ottaviano, Y. L., Celano, P., Hamilton, S. R., Davidson, N. E., and Baylin, S B. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon Nat. Genet., 7: 536-540, 1994.
20. Yisraeli, J., Frank, D., Razin, A., and Cedar, H Effect of in vitro DNA methylation on β-globin gene expression. Proc Natl. Acad. Sci. USA, 85: 4638-4642, 1988.
21. Thompson, J. P., Simkevich, C P., Holness, M. A., Kang, A H., and Raghow, R. In vitro methylation of the promoter and enhancer of pro α 1 (T) collagen gene leads to its transcriptional inactivation. J Biol Chem., 266: 2549-2556, 1991.
22. Tate, P H., and Bird, A. P. Effects of DNA methylation on DNA binding proteins and gene expression. Curr. Biol., 3: 226-231, 1993.
23. Eden, S., and Cedar, H Role of DNA methylation in the regulation of transcription. Curr Biol., 4: 225-259, 1994.
24. Riggs, A. D., and Pleifer, G. D. X-chromosome inactivation and cell memory Trends Genet., 8: 169-173, 1992.
25. Ferguson-Smith, A. C., Sasaki, H., Cattanach, B M., and Suram, M. A Parental-origin-specific epigenetic modification of the mouse H19 gene Nature (Lond.), 362: 751-755, 1993.
26. Stoger, R., Kubicka, P., Liu, C. G., Kafri, T., Razin, A., Cedar, H., and Barlow, D. P. Maternal-specific methylation of the imprinted mouse Igf2r locus identifies the expressed locus as carrying the imprinting signal Cell, 73: 61-71, 1993.
27. Bartolomei, M. S., Webber, A. L., Brunkow, M. E., and Tilghman, S. M. Epigenetic mechanisms underlying the imprinting of the mouse H19 gene, Genes Dev., 7: 1663-1673, 1993.
28. Li, E., Beard, C., and Jaenisch, R Role for DNA methylation in genomic imprinting (see Comments) Nature (Lond.), 366: 362-365, 1993.
29. Antequera, F., Boyes, J., and Bird, A. High levels of de novo methylation and altered chromatin structure at CpG islands in the cell lines. Cell, 62: 503-514, 1990.
30. Ferguson, A T., Lapidus, R G., Baylin, S. B., and Davidson, N E. Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression. Cancer Res., 55: 2279-2283, 1995.
31. Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D-S. R., Gnarra, J. R., Linehan, W. M., and Baylin, S B. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma Proc. Natl Acad. Sci. USA, 91: 9700-9704, 1994.
32. Merlo, A., Herman, J G., Mao, L., Lee, D J., Gabrielson, E., Burger, P C., Baylin, S B., and Sidransky, D. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor P16/CDKN2/MTS1 in human cancers Nat. Med., 1: 686-692, 1995.
33. Bandyopadhyay, G K., Imagawa, W., Wallace, D., and Nandi, S. Linoleate metabolites enhance the in vitro proliferative response of mouse mammary epithelial cells to epidermal growth factor. J. Biol. Chem., 262: 2750-2756, 1987.
34. Kuhlem, U., Gavora, J. S., Spencer, J. L., Bernon, D. E., and Sabour, M. Incidence of endogenous viral genes in two strains of White Leghorn chickens selected for egg production and susceptibility or resistance to Marek's disease. Theor. Appl. Genet., 77: 26-32, 1989.
35. Sambrook, J., Fritsch, E F., and Maniatis, T Molecular Cloning A Laboratory Manual. pp. F.6-F.7. Cold Spring Harbor, NY. Cold Spring Harbor Laboratory, 1989.
36. Knudson, A. G. Antioncogenes and human cancer. Proc Natl Acad. Sci. USA, 90: 10914-10921, 1993.
37. Makos, M., Nelkin, B. D., Chazin, V. R., Cavenee, W K., Brodeur, G. M., and Baylin, S. B. DNA hypermethylation is associated with 17p allelic loss in neural tumors. Cancer Res., 53: 2715-2718, 1993.
38. Jones, P A., Wolkowicz, M. J., Rideout, W. M., III, Gonzales, F. A., Marziasz, C. M., Coetzee, G. A., and Tapscott, S. J De novo methylation of the MyoD1 CpG island during the establishment of immortal cell lines. Proc. Natl. Acad. Sci. USA, 87: 6117-6121, 1990.
39. Herman, J. G., Merlo, A., Mao, L., Lapidus, R G., Issa, J. P J., Davidson, N E., Sidransky, D., and Baylin, S. B. Inactivation of the CDKN2/P16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55: 4525-4530, 1995.
40. Comb, M., and Goodman, H. M. CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2 Nucleic Acids Res., 18: 3975-3982, 1990.
41. Prendergast, G. C., and Ziff, E. B. Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. Science (Washington DC), 251: 186-189, 1991.
42. Hansen, R. S., Ellis, N A., and Gartler, S. M. Demethylation of specific sites in the 5′ region of the inactive X-linked human phosphoglycerate kinase gene correlated with the appearance of nuclease sensitivity and gene expression. Mol Cell Biol., 8: 4692-4699, 1988.
43. Andrulis, E. L., and Barrett, M T. DNA methylation patterns associated with asparagine synthetase in asparagine-over-producing and auxotrophic cells. Mol. Cell. Biol., 9: 2922-2927, 1989.
44. Hengst-Zhang, J. A., and Weitzman, S. A. Methylation inhibits the interaction of DNA binding proteins with a potential c-abl intron regulatory element Biochem. Biophys. Res Commun., 186: 1515-1521, 1992.
45. Becker, P. B., Ruppert, S., and Schutz, G. Genomic footprinting reveals cell type-specific DNA binding of ubiquitous factors. Cell, 51: 435-443, 1987.
46. Iguchi-Ariga, M. M., and Schaffner, W. CpG methylation of the cAMP-responsive enhancer-promoter sequence TGACGTCA abolishes specific factor binding as well as transcriptional activation. Genes Dev., 3: 612-619, 1989.
47. Klages, S., Mollers, B., and Renkawitz, R The involvement of demethylation in the myeloid-specific function of the mouse M lysozyme gene downstream enhancer Nucleic Acids Res., 20: 1925-1932, 1992.
48. Karpinski, B. A., Yang, L. H., Cacheris, P., Morle, G. D., and Leiden, J. M. The first intron of the 4F2 heavy-chain gene contains a transcriptional enhancer element that binds multiple nuclear proteins Mol Cell Biol., 9: 2588-2597, 1989.
49. Oshima, R G., Abrams, L., and Kulesh, D. Activation of an intron enhancer within the keratin 18 gene by expression of c-fos and c-jun in undifferentiated F9 embryonal carcinoma cells. Genes Dev., 4: 835-848, 1990.
50. Chapman, B. S., Thayer, R. M., Vincent, K. A., and Haigwood, N. L. Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells. Nucleic Acids Res., 19: 3979-3986, 1991.
51. Boyes, J., and Bird, A P DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein. Cell, 64: 1123-1134, 1991.
52. Lewis, J. D., Meehan, R. R., Henzel, W J., Maurer-Fogy, I., Jeppesen, P., Klein, F., and Bird, A. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell, 69: 905-914, 1992.
53. Jost, J. P., Saluz, H P., and Pawlak, A. Estradiol down regulates the binding activity of an avian vitellogenin gene repressor (MDBP-2) and triggers a gradual demethylation of the mCpG pair of its DNA binding site. Nucleic Acids Res., 19: 5771-5775, 1991.
54. Sneller, M. C., and Gunter, K C DNA methylation alters chromatin structure and regulates Thy-1 expression in EL-4 T cells. J. Immunol., 138: 3505-5313, 1987.
55. Keshet, I., Lieman-Hurwitz, J., and Cedar, H. DNA methylation affects the formation of active chromatin Cell, 44: 535-543, 1986.